Sendai virion transcriptase complex: polyeptide composition and inhibition by virion envelope proteins.
Sendai virions, disrupted in 2% Triton X-100 in 1 M KCl, were separated into nucleocapsids and envelope proteins by centrifugation. The nucleocapsids, representing 46% of the virion proteins, had a buoyant density of 1.29 gm/cm(3) in D(2)O sucrose. RNA-dependent transcriptase activity associated with them had a ninefold greater specific activity than transcriptase assayed in unfractionated detergent-disrupted virions. These enzyme-active nucleocapsids contained only two polypeptides, the largest virion polypeptide (molecular weight 75,000) and the nucleocapsid structure unit (molecular weight 60,000). Virion envelope proteins, either glycoproteins or nonglycosylated matrix protein, inhibited nucleocapsid-associated polymerase activity; brief heat denaturation abolished their inhibitory activity. Yeast RNA stimulated nucleocapsid-associated enzyme, suggesting that stimulatory polyanions act at the enzyme-template level.
D002474:Cell-Free System; D002499:Centrifugation, Density Gradient; D012321:DNA-Directed RNA Polymerases / Q000032:analysis / Q000037:antagonists & inhibitors / Q000378:metabolism*; D004591:Electrophoresis, Polyacrylamide Gel; D006020:Glycopeptides / Q000494:pharmacology; D006160:Guanosine Triphosphate / Q000378:metabolism; D009698:Nucleoproteins / Q000032:analysis; D010222:Parainfluenza Virus 1, Human / Q000032:analysis / Q000201:enzymology*; D010455:Peptides / Q000032:analysis / Q000494:pharmacology; D012313:RNA / Q000494:pharmacology; D013501:Surface-Active Agents; D014316:Tritium; D014764:Viral Proteins / Q000032:analysis / Q000494:pharmacology*; D015003:Yeasts
D006020:Glycopeptides; D009698:Nucleoproteins; D010455:Peptides; D013501:Surface-Active Agents; D014764:Viral Proteins; D014316:Tritium; D012313:RNA; D006160:Guanosine Triphosphate; D012321:DNA-Directed RNA Polymerases